353 related articles for article (PubMed ID: 9764565)
1. Comparison of the effectiveness of 2,3-dimercaptopropanol (BAL) and meso-2,3-dimercaptosuccinic acid (DMSA) as protective agents against mercuric chloride-induced nephrotoxicity in rats.
de la Torre A; Bellés M; Llobet JM; Mayayo E; Domingo JL
Biol Trace Elem Res; 1998 Jul; 63(1):1-10. PubMed ID: 9764565
[TBL] [Abstract][Full Text] [Related]
2. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
Juresa D; Blanusa M; Kostial K
Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
[TBL] [Abstract][Full Text] [Related]
4. 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid, and meso-2,3-dimercaptosuccinic acid inhibit delta-aminolevulinate dehydratase from human erythrocytes in vitro.
Nogueira CW; Santos FW; Soares FA; Rocha JB
Environ Res; 2004 Mar; 94(3):254-61. PubMed ID: 15016592
[TBL] [Abstract][Full Text] [Related]
5. DMPS and N-acetylcysteine induced renal toxicity in mice exposed to mercury.
Brandão R; Santos FW; Zeni G; Rocha JB; Nogueira CW
Biometals; 2006 Aug; 19(4):389-98. PubMed ID: 16841248
[TBL] [Abstract][Full Text] [Related]
6. Further study of effects of chelating agents on excretion of inorganic mercury in rats.
Shimada H; Fukudome S; Kiyozumi M; Funakoshi T; Adachi T; Yasutake A; Kojima S
Toxicology; 1993 Jan; 77(1-2):157-69. PubMed ID: 8442011
[TBL] [Abstract][Full Text] [Related]
7. Reductions in renal mass and the nephropathy induced by mercury.
Zalups RK
Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined administration of captopril and DMSA on arsenite induced oxidative stress and blood and tissue arsenic concentration in rats.
Kalia K; Narula GD; Kannan GM; Flora SJ
Comp Biochem Physiol C Toxicol Pharmacol; 2007 Jan; 144(4):372-9. PubMed ID: 17188940
[TBL] [Abstract][Full Text] [Related]
9. 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase lead-induced inhibition of delta-aminolevulinate dehydratase in vitro and ex vivo.
Santos FW; Rocha JB; Nogueira CW
Toxicol In Vitro; 2006 Apr; 20(3):317-23. PubMed ID: 16168622
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity of simultaneous exposure to mercury and uranium in comparison to individual effects of these metals in rats.
Sánchez DJ; Bellés M; Albina ML; Sirvent JJ; Domingo JL
Biol Trace Elem Res; 2001; 84(1-3):139-54. PubMed ID: 11817685
[TBL] [Abstract][Full Text] [Related]
11. Acute mercury intoxication and use of chelating agents.
Boscolo M; Antonucci S; Volpe AR; Carmignani M; Di Gioacchino M
J Biol Regul Homeost Agents; 2009; 23(4):217-23. PubMed ID: 20003760
[TBL] [Abstract][Full Text] [Related]
12. Comparison of standard chelating agents for acute mercuric chloride poisoning in mice.
Jones MM; Basinger MA; Weaver AD; Davis CM; Vaughn WK
Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):363-72. PubMed ID: 7367752
[TBL] [Abstract][Full Text] [Related]
13. Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat.
Maiorino RM; Aposhian MM; Xu ZF; Li Y; Polt RL; Aposhian HV
J Pharmacol Exp Ther; 1993 Dec; 267(3):1221-6. PubMed ID: 8263783
[TBL] [Abstract][Full Text] [Related]
14. Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization in rats.
Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
J Appl Toxicol; 1997; 17(1):71-4. PubMed ID: 9048230
[TBL] [Abstract][Full Text] [Related]
15. Increased inorganic mercury in spinal motor neurons following chelating agents.
Ewan KB; Pamphlett R
Neurotoxicology; 1996; 17(2):343-9. PubMed ID: 8856730
[TBL] [Abstract][Full Text] [Related]
16. 2,3-Dimercapto-1-propanol does not alter the porphobilinogen synthase inhibition but decreases the mercury content in liver and kidney of suckling rats exposed to HgCl2.
Roza T; Peixoto NC; Welter A; Flores EM; Pereira ME
Basic Clin Pharmacol Toxicol; 2005 Apr; 96(4):302-8. PubMed ID: 15755313
[TBL] [Abstract][Full Text] [Related]
17. Beneficial role of monoesters of meso-2,3-dimercaptosuccinic acid in the mobilization of lead and recovery of tissue oxidative injury in rats.
Saxena G; Pathak U; Flora SJ
Toxicology; 2005 Oct; 214(1-2):39-56. PubMed ID: 16019123
[TBL] [Abstract][Full Text] [Related]
18. Isolated rat kidney tubules as a screening system for arsenic antidotes.
Mückter H; Islambouli S; Doklea E; Hopfer C; Szinicz L; Fichtl B; Forth W
Toxicol Appl Pharmacol; 1993 Jul; 121(1):118-28. PubMed ID: 8393218
[TBL] [Abstract][Full Text] [Related]
19. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat.
Gong Z; Evans HL
Toxicol Appl Pharmacol; 1997 Jun; 144(2):205-14. PubMed ID: 9194404
[TBL] [Abstract][Full Text] [Related]
20. DMPS as a rescue agent for the nephropathy induced by mercuric chloride.
Zalups RK; Gelein RM; Cernichiari E
J Pharmacol Exp Ther; 1991 Jan; 256(1):1-10. PubMed ID: 1671092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
